These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36455864)

  • 1. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
    Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
    Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitotic rate as a prognostic biomarker after preoperative radiotherapy for high-grade limb/trunk soft tissue sarcoma.
    Ouyang Z; Wang T; Brown J; Orosz Z; Trent S; Cosker T; Branford White H; Whitwell D; Guo X; Leonard Maxime Gibbons C
    Radiother Oncol; 2024 Nov; 200():110482. PubMed ID: 39159680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
    Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
    Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
    Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
    Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
    J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The profile of extremity and trunk soft tissue sarcoma in a tertiary referral center.
    Mahmoud AMA; Mahmoud M; Charaf A; Moneer MM
    J Egypt Natl Canc Inst; 2017 Jun; 29(2):89-94. PubMed ID: 28462849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
    Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
    Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
    Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y
    Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma.
    Zhao R; Yu X; Feng Y; Wang J; Mao Y; Yin W; Zhang Z; Guo X; Ma S
    Jpn J Clin Oncol; 2018 Sep; 48(9):799-805. PubMed ID: 30060202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
    Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
    Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
    Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value and association of the age-adjusted Charlson Comorbidity Index with sarcopenia within patients with gastric cancer after radical resection.
    Shao J; Gao Z; Shen Q; Zhi H; Wang X; Zheng J; Chen Y; Shi A; Wu D; Cai W; Chen X; Shen X
    J Gastrointest Surg; 2024 Jul; 28(7):1089-1094. PubMed ID: 38703987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
    Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
    Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
    Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
    Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.
    Takahara N; Nakai Y; Saito K; Sasaki T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Isayama H; Koike K
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1828-1835. PubMed ID: 32267557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity, body mass index, and performance status as prognostic factors in older patients with soft-tissue sarcoma.
    Tamiya H; Imura Y; Wakamatsu T; Takenaka S
    J Geriatr Oncol; 2022 Jun; 13(5):673-681. PubMed ID: 35219635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.
    Zhou S; Zhang XH; Zhang Y; Gong G; Yang X; Wan WH
    Cancer Manag Res; 2022; 14():1683-1691. PubMed ID: 35573259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
    Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Eur J Surg Oncol; 2019 Dec; 45(12):2465-2472. PubMed ID: 31350072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.